Citrullination, a transformative protein post-translational modification, is gaining recognition for its wide-ranging impact on cellular function and human disease.

As businesses seek effective solutions, AI is emerging as a transformative force, particularly at the intersection of ...

New bioluminescent sensors using engineered firefly luciferases provide accurate pH monitoring in living cells, enhancing ...

Chronotherapy for asthma reveals that afternoon inhaled corticosteroids significantly improve lung function and reduce ...

The biostimulants market is estimated at USD 4.46 billion in 2025 and is projected to reach USD 7.84 billion by 2030, at a CAGR of 11.9% from ...

The biostimulants market is estimated at USD 4.46 billion in 2025 and is projected to reach USD 7.84 billion by 2030, at a CAGR of 11.9% from 2025 to 2030, according to a report published by ...

Analysis of blood samples from patients treated with Aramchol in ARMOR (Ph3 MASH Study) provides new and important insights into the biochemical and physiological ...

AI advancements in myopia detection and prediction are explored, emphasizing the need for high-quality data and addressing clinical application challenges.

Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, and Okava Pharmaceuticals, Inc.

Nimacimab shows comparable weight loss to monlunabant and tirzepatide alone, and an additive effect in combination with ...

Galmed Pharmaceuticals Ltd. ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company dedicated to developing novel treatments for liver, cardiometabolic, and gastrointestinal oncology ...